Juvenile Arthritis
TNF inhibitors do not increase cancer risk in children with juvenile idiopathic arthritis, says new study
A group of biologic drugs called tumour necrosis factor inhibitors, which are used to treat children with juvenile idiopathic arthritis, are not associated with a significantly increased risk of cancer, according to research presented at the American College of Rheumatology Annual Scientific Meeting. Continue reading
Most children with juvenile idiopathic arthritis are diagnosed with different form of arthritis as adults
The diagnosis of juvenile idiopathic arthritis is reclassified to another form of arthritis in two-thirds of people in adulthood, says research in RMD Open. Continue reading
Cognitive behavioural therapy improves sleep in people with chronic pain – new study
People with painful conditions such as arthritis and fibromyalgia could get a better night’s sleep through cognitive behavioural therapy (CBT), says research in the Journal of Clinical Sleep Medicine.
A team from the University of Warwick developed a scale that measures beliefs about pain and sleep, and examined overall quality of sleep in four groups of people who had long-term pain and bad sleeping patterns. Continue reading
Depression linked to disease activity and disability in adolescents with arthritis, says study
A clear association has been found in a study between depression symptom severity and the level of disease activity and disability in adolescents with juvenile inflammatory arthritis (JIA). Continue reading
Children with juvenile inflammatory arthritis more prone to type 1 diabetes, says study
A new study involving more than 9,000 patients has shown that type 1 diabetes occurs more frequently in children with Juvenile Inflammatory Arthritis (JIA) than in the general population.
The results of the study were presented at this year’s European League Against Rheumatism Annual Congress (EULAR 2016) where it was stated that a better understanding of this link between diabetes and JIA may lead to new preventative and therapeutic interventions in both diseases. Continue reading
